Recent Advancements in Biomedical Applications Of Carboxymethyl Cellulose
Main Article Content
Abstract
Carboxymethyl Cellulose (CMC), a hydrophilic polymer derived from cellulose, has gained considerable attention in the biomedical sector due to its outstanding physicochemical properties and biocompatibility. Recent advancements have broadened its range of applications, particularly in wound care, drug delivery, and tissue engineering. In wound dressing, CMC's hydrogel-forming capability creates a moist healing environment, enhances exudate absorption, and improves antimicrobial effectiveness by incorporating nanoparticles. In drug delivery, CMC-based systems have shown potential for controlled release and targeted delivery of therapeutics, improving pharmacokinetics and patient adherence. Additionally, CMC's incorporation into 3D bioprinting has transformed tissue engineering by offering a versatile scaffold material that promotes cell growth and differentiation. This review explores the latest research and developments in CMC's biomedical applications, emphasizing its multifunctional role and its potential to revolutionize therapeutic strategies. The future outlook of CMC in biomedicine is discussed, with attention to its evolving applications and the challenges ahead in optimizing its clinical use.